SERPINA3 and chronic kidney disease: We recently evaluated urinary SerpinA3 (uSerpinA3) in an experimental transition model from AKI to CKD, in which a temporal progressive increase that preceded the elevation of classic CKD markers, such as proteinuria and fibrosis, was observed, with the greater the excretion of uSerpinA3, the greater fibrosis.